Metabolic Tumor Volume (MTV) Is a Predictor of Survival in Borderline Pancreatic Cancers Treated With Neoadjuvant Therapy

Journal article

Peer reviewed

K. Latifi, A. Cruz, E. Mellon, T. Strom, J. Freilich, G. Springett, R. Kim, M. Malafa, R. Shridhar and S. Hoffe

International journal of radiation oncology, biology, physics, Vol.90(1), pp.S365-S365

2014-09-01

Metrics

10 Record Views

This output has contributed to the advancement of the following goals:

Source: InCites

Title: Metabolic Tumor Volume (MTV) Is a Predictor of Survival in Borderline Pancreatic Cancers Treated With Neoadjuvant Therapy
Creators: K. Latifi - Moffitt Cancer Center
A. Cruz - University of South Florida
E. Mellon - Moffitt Cancer Center
T. Strom - Moffitt Cancer Center
J. Freilich - Moffitt Cancer Center
G. Springett - Moffitt Cancer Center
R. Kim - Moffitt Cancer Center
M. Malafa - Moffitt Cancer Center
R. Shridhar - Moffitt Cancer Center
S. Hoffe - Moffitt Cancer Center
Publication Details: International journal of radiation oncology, biology, physics, Vol.90(1), pp.S365-S365
Publisher: Elsevier Inc
Academic Unit: Miller School of Medicine; UMMG Dept of Radiation Oncology
Language: English
Resource Type: Journal article
Record Identifier: 991031785745202976